Nitrate Medications, Fractures, and Change in Bone Mineral Density in Postmenopausal Women: Results from the Women's Health Initiative

被引:8
|
作者
Golchin, Negar [1 ]
Hohensee, Chancellor [2 ]
LaCroix, Andrea [3 ]
Gray, Shelly L. [1 ]
机构
[1] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
OSTEOPOROSIS; FRACTURE PREVENTION; THERAPEUTICS; AGING; EPIDEMIOLOGY; OXIDE DONOR NITROGLYCERIN; NITRIC-OXIDE; ORGANIC NITRATES; PREVENTION; THERAPY; RISK;
D O I
10.1002/jbmr.2838
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitrate medications may increase bone mineral density (BMD), although information on fracture outcomes is sparse. We examined the association of nitrate medications with fractures (hip, wrist/arm, and total fractures) and changes in BMD (hip, spine, and whole body) in the Women's Health Initiative (WHI) Clinical Trials and Observational Study. A total of 139,211 postmenopausal women 50 to 79 years old without history of hip fracture were included in this prospective study. Medication use was ascertained directly from drug containers at baseline during in-person interviews in 1993 to 1998. Exposure measures included any use (use/non-use), type of nitrate (as-needed, maintenance) and duration of use (5 years, >5 years). We used separate multivariable Cox proportional hazard models to analyze associations between each exposure and fracture outcome, with results presented as hazard ratios (HRs) and 95% confidence intervals (CIs). Multivariable linear regression models were used to examine 3-year and 6-year changes in BMD. At baseline, 1.2% (n=1647) women were using a nitrate. During the mean +/- SD follow-up of 7.7 +/- 1.5 years through 2005, women experienced 1582 hip fractures, 5156 wrist or arm fractures, and 22, 589 total fractures. After adjustment for confounders, nitrate use was not statistically associated with risk for hip (HR, 0.81; 95% CI, 0.56 to 1.18), wrist/arm (HR, 0.95; 95% CI, 0.74 to 1.23), or total fractures (HR, 0.96; 95% CI, 0.85 to 1.08). As-needed nitrate use, but not maintenance therapy, was associated with a lower risk of total fractures (HR, 0.77; 95% CI, 0.62 to 0.95) and wrist/arm fractures (HR, 0.57; 95% CI, 0.34 to 0.98). Nitrate use was not associated with 3-year or 6-year changes in BMD at any site. We conclude that any nitrate use was not significantly associated with lower risk of fractures or higher BMD; however, as-needed nitrate use was associated with lower risks of total and wrist/arm fractures. (c) 2016 American Society for Bone and Mineral Research.
引用
收藏
页码:1760 / 1766
页数:7
相关论文
共 50 条
  • [41] Antiepileptic Drug Use, Falls, Fractures, and BMD in Postmenopausal Women: Findings From the Women's Health Initiative (WHI)
    Carbone, Laura D.
    Johnson, Karen C.
    Robbins, John
    Larson, Joseph C.
    Curb, J. David
    Watson, Kathleen
    Gass, Margery
    LaCroix, Andrea Z.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (04) : 873 - 881
  • [42] Effect of exercise on bone mineral density in postmenopausal women
    Ross, MD
    Denegar, CR
    STRENGTH AND CONDITIONING JOURNAL, 2001, 23 (04) : 30 - 35
  • [43] Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative
    Park, Na-Jin
    Chang, Yuefang
    Bender, Catherine
    Conley, Yvette
    Chlebowski, Rowan T.
    van Londen, G. J.
    Foraker, Randi
    Wassertheil-Smoller, Sylvia
    Stefanick, Marcia L.
    Kuller, Lewis H.
    PLOS ONE, 2017, 12 (09):
  • [44] Romosozumab in Postmenopausal Women with Low Bone Mineral Density
    McClung, Michael R.
    Grauer, Andreas
    Boonen, Steven
    Bolognese, Michael A.
    Brown, Jacques P.
    Diez-Perez, Adolfo
    Langdahl, Bente L.
    Reginster, Jean-Yves
    Zanchetta, Jose R.
    Wasserman, Scott M.
    Katz, Leonid
    Maddox, Judy
    Yang, Yu-Ching
    Libanati, Cesar
    Bone, Henry G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 412 - 420
  • [45] Evaluation of Bone Mineral Density in Postmenopausal Women in Kuwait
    Gupta, Renu
    Al-saeed, Osama
    Azizieh, Fawaz
    Albusairi, Abdullatif
    Gupta, Pushpak
    Mohammed, Ahmed
    JOURNAL OF CLINICAL DENSITOMETRY, 2012, 15 (02) : 211 - 216
  • [46] Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: The OPUS study
    Briot, Karine
    Paternotte, Simon
    Kolta, Sami
    Eastell, Richard
    Reid, David M.
    Felsenberg, Dieter
    Glueer, Claus C.
    Roux, Christian
    BONE, 2013, 57 (01) : 232 - 236
  • [47] The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change
    Chen, Chiung-Ya
    Chen, Szu-Tah
    Huang, Bie-Yu
    Hwang, Jawl-Shan
    Lin, Jen-Der
    Liu, Feng-Hsuan
    ENDOCRINE JOURNAL, 2018, 65 (11) : 1101 - 1109
  • [48] Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures
    Minisola, S
    Pacitti, MT
    Ombricolo, E
    Costa, G
    Scarda, A
    Palombo, E
    Rosso, R
    MATURITAS, 1998, 29 (03) : 265 - 270
  • [49] Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
    Liang, Ying
    Huang, Jian
    Tian, Jing-bin
    Cao, Yuan-yuan
    Zhang, Guo-ling
    Wang, Chun-gang
    Cao, Ying
    Li, Jian-rong
    CLINICAL INTERVENTIONS IN AGING, 2016, 11 : 153 - 157
  • [50] Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women
    Hmamouchi, Ihsane
    Allali, Fadoua
    Khazzani, Hamza
    Bennani, Loubna
    Mansouri, Leila E. L.
    Ichchou, Linda
    Cherkaoui, Mohammed
    Abouqal, Redouane
    Hajjaj-Hassouni, Najia
    BMC PUBLIC HEALTH, 2009, 9 : 388